PIDTC: Hematopoietic Stem Cell Transplantation Using Carrier Donors for CD40L Deficiency Results in Excellent Outcomes
Sep 7, 2022 ·
1m 54s
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using...
show more
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the journal Blood Advances on June 28, 2022, titled "HSCT using carrier donors for CD40L deficiency results in excellent immune function and higher CD40L expression in cTfh."
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
show less
Read the paper here: https://ashpublications.org/bloodadvances/article/6/12/3751/485000/HSCT-using-carrier-donors-for-CD40L-deficiency
Learn more about PIDTC: https://www1.rarediseasesnetwork.org/cms/pidtc
Information
| Author | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
